BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24124738)

  • 1. [Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma].
    Song DJ; Yue LF; Yang HY; Jia XY; Zhang JJ; Xu YL; Guo F; Wang JX
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1876-80. PubMed ID: 24124738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
    Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
    Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between mRNA expression and promoter methylation status of p73 gene in peripheral blood among children with Wilms' tumor].
    Song DJ; Yue LF; Zhang D; Yang HY; Fan YX; Yue M; Pei H; Wang JX
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Aug; 15(8):638-43. PubMed ID: 23965876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.
    Senanayake U; Koller K; Pichler M; Leuschner I; Strohmaier H; Hadler U; Das S; Hoefler G; Guertl B
    Hum Pathol; 2013 Mar; 44(3):336-45. PubMed ID: 22995329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
    An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
    J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.
    Song D; Yue L; Wu G; Ma S; Yang H; Liu Q; Zhang D; Xia Z; Jia J; Wang J
    J Clin Pathol; 2016 Jan; 69(1):12-8. PubMed ID: 26184366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
    Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
    Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ZO-1 gene methylation status and its clinical significance in children with non-Hodgkin lymphoma].
    Diao YQ; Qu F; Yang MJ; Meng JH; Zhu XL; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):619-23. PubMed ID: 24927439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.
    Murphy AJ; Pierce J; de Caestecker C; Taylor C; Anderson JR; Perantoni AO; de Caestecker MP; Lovvorn HN
    J Pediatr Surg; 2012 Jun; 47(6):1239-49. PubMed ID: 22703800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
    Morris MR; Hesson LB; Wagner KJ; Morgan NV; Astuti D; Lees RD; Cooper WN; Lee J; Gentle D; Macdonald F; Kishida T; Grundy R; Yao M; Latif F; Maher ER
    Oncogene; 2003 Oct; 22(43):6794-801. PubMed ID: 14555992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
    Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
    Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
    Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
    Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the RASSF1A promoter is predictive of poor outcome among patients with Wilms tumor.
    Ohshima J; Haruta M; Fujiwara Y; Watanabe N; Arai Y; Ariga T; Okita H; Koshinaga T; Oue T; Hinotsu S; Nakadate H; Horie H; Fukuzawa M; Kaneko Y
    Pediatr Blood Cancer; 2012 Sep; 59(3):499-505. PubMed ID: 22457227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome.
    Kempkensteffen C; Hinz S; Schrader M; Christoph F; Magheli A; Krause H; Schostak M; Miller K; Weikert S
    Cancer Lett; 2007 Sep; 254(2):227-35. PubMed ID: 17449173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.